Pharmacokinetics and pharmacodynamics of a fixed-dose combination of gemigliptin/metformin sustained release 25/500 mg compared to the loose combination in healthy male subjects

A fixed-dose combination (FDC) of gemigliptin/metformin can improve the medication adherence in patients with type 2 diabetes mellitus (T2DM). In this study, the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of gemigliptin and metformin were compared between FDC and the corresponding loose...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Clin Pharmacol
Hlavní autoři: Jin, Xuanyou, Kim, Eunwoo, Huh, Ki Young, Hwang, Inyoung, Cho, Joo-Youn, Yu, Kyung-Sang, Lee, SeungHwan
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Society for Clinical Pharmacology and Therapeutics 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7136079/
https://ncbi.nlm.nih.gov/pubmed/32274380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2020.28.e2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky